nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study
|
Alavi, Maryam |
|
2019 |
72 |
C |
p. 99-105 |
artikel |
2 |
Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination
|
Brown, Graham |
|
2019 |
72 |
C |
p. 24-32 |
artikel |
3 |
Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs
|
Høj, Stine Bordier |
|
2019 |
72 |
C |
p. 11-23 |
artikel |
4 |
Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination
|
Katzman, Caroline |
|
2019 |
72 |
C |
p. 33-39 |
artikel |
5 |
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids
|
Barocas, Joshua A. |
|
2019 |
72 |
C |
p. 160-168 |
artikel |
6 |
Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada
|
Selfridge, Marion |
|
2019 |
72 |
C |
p. 106-113 |
artikel |
7 |
Editorial Board
|
|
|
2019 |
72 |
C |
p. ii |
artikel |
8 |
Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all
|
Grebely, Jason |
|
2019 |
72 |
C |
p. 1-10 |
artikel |
9 |
Evidence-making hepatitis C cure: Towards a science that knows more carefully
|
Rhodes, Tim |
|
2019 |
72 |
C |
p. 40-46 |
artikel |
10 |
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston
|
Beiser, Marguerite E. |
|
2019 |
72 |
C |
p. 129-137 |
artikel |
11 |
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units
|
Valencia, Jorge |
|
2019 |
72 |
C |
p. 181-188 |
artikel |
12 |
Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review
|
Caven, Madeleine |
|
2019 |
72 |
C |
p. 169-176 |
artikel |
13 |
Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review
|
Socías, M. Eugenia |
|
2019 |
72 |
C |
p. 146-159 |
artikel |
14 |
Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs
|
E. Williams, Beth |
|
2019 |
72 |
C |
p. 138-145 |
artikel |
15 |
Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project
|
Rojas Rojas, Teresa |
|
2019 |
72 |
C |
p. 61-68 |
artikel |
16 |
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver, Canada
|
Holeksa, Julie |
|
2019 |
72 |
C |
p. 177-180 |
artikel |
17 |
Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals
|
Bryant, Joanne |
|
2019 |
72 |
C |
p. 77-83 |
artikel |
18 |
Mapping the hepatitis C cascade of care in people attending drug treatment services in England: A data linkage study
|
Ireland, G. |
|
2019 |
72 |
C |
p. 55-60 |
artikel |
19 |
Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting
|
Overton, Kristen |
|
2019 |
72 |
C |
p. 123-128 |
artikel |
20 |
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study
|
Williams, Bridget |
|
2019 |
72 |
C |
p. 91-98 |
artikel |
21 |
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department
|
Hutton, J. |
|
2019 |
72 |
C |
p. 84-90 |
artikel |
22 |
Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia
|
Harney, Brendan L. |
|
2019 |
72 |
C |
p. 195-198 |
artikel |
23 |
Reinfection in a large cohort of prison inmates with sustained virological response after treatment of chronic hepatitis C in Catalonia (Spain), 2002–2016
|
Marco, Andrés |
|
2019 |
72 |
C |
p. 189-194 |
artikel |
24 |
Rural risk environments for hepatitis c among young adults in appalachian kentucky
|
Cloud, David H. |
|
2019 |
72 |
C |
p. 47-54 |
artikel |
25 |
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?
|
Makarenko, Iuliia |
|
2019 |
72 |
C |
p. 69-76 |
artikel |
26 |
What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada
|
Krajden, Mel |
|
2019 |
72 |
C |
p. 114-122 |
artikel |